Résumé
This is a Horizon Europe recognition prize call for outstanding research teams under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) joint undertaking, with an application deadline of 2 September 2026. The call operates within the 2021-2027 Horizon Europe programme period. No attachment documents are available to provide additional details on eligibility criteria, budget, or specific requirements.
Analyse d'adéquation
This is a recognition prize for outstanding research teams under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) program, focused on clinical research in infectious diseases and global health. Acme Corporation, a semiconductor and AI company, is ineligible as the call explicitly targets research institutions and universities conducting clinical trials, which falls entirely outside the client's domain.
Scores détaillés
Brief exécutif
LowPas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.
Description
HORIZON Recognition Prize Call: HORIZON-JU-EDCTP3-2026-OUTSRESEARCHTEAMPRIZE Programme period: 2021 - 2027